Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety, PK, and Food Effect of IN-114199 in Healthy Participants
NCT06736912Phase 1Not yet recruiting
- Sponsor
- HK inno.N Corporation
- Start
- Dec 2024
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of IN-114199 in chronic idiopathic constipation (CIC) (9 arms), sponsored by HK inno.N Corporation. Primary endpoints: Adverse Event, Vital Sign and 4 more. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
IN-114199
03
Conditions
chronic idiopathic constipation (CIC)
Beyond the preview
Go deeper on NCT06736912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06736912.